Charles Schwab Investment Management »

Zentalis Pharmaceuticals shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.8M 446k 15.15
2023-09-30 $8.9M 442k 20.06
2023-06-30 $11M 406k 28.21
2023-03-31 $5.7M 334k 17.20
2022-12-31 $6.8M 336k 20.14
2022-09-30 $7.0M 324k 21.66
2022-06-30 $9.0M 321k 28.10
2022-03-31 $12M 268k 46.14
2021-12-31 $22M 261k 84.06
2021-09-30 $17M 253k 66.64
2021-06-30 $8.2M 154k 53.20
2021-03-31 $5.6M 129k 43.39
2020-12-31 $6.5M 125k 51.94
2020-09-30 $2.8M 87k 32.70
2020-06-30 $3.2M 66k 48.02